GT Biopharma, Inc. (GTBP)
NASDAQ · Healthcare
GT Biopharma, Inc. Net Income 2010–2020
GT Biopharma, Inc. annual/quarterly net income history and growth rate from 2010 to 2021. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- GT Biopharma, Inc. net income for the quarter ending September 30, 2021 was -5.5 M, a 89.60% increase year-over-year.
- GT Biopharma, Inc. net income for the twelve months ending September 30, 2021 was -42.9 M, a 31.01% increase year-over-year.
- GT Biopharma, Inc. annual net income for 2020 was -28.3 M, a 26.78% decrease from 2019.
- GT Biopharma, Inc. annual net income for 2019 was -38.6 M, a 73.19% decrease from 2017.
- GT Biopharma, Inc. annual net income for 2017 was -144.2 M, a 1575.96% decrease from 2016.
- GT Biopharma, Inc. annual net income for 2016 was 9.8 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
GT Biopharma, Inc. Net Income — FAQ
GT Biopharma, Inc. (GTBP) net income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is GT Biopharma, Inc.'s net income?
GT Biopharma, Inc. (GTBP) reported net income of -$28M for fiscal 2020.
Where can I see GTBP's net income history?
The chart and table above show GT Biopharma, Inc.'s net income by year and by quarter, including the growth rate.